Abstract:The requirement for U.S. investigators to obtain “traditional” in-depth informed consent consisting of the eight “required” elements when performing collaborative research in international settings can present significant cultural challenges to obtaining individual informed consent and hence preclude the conduct of important research. The Common Rule, however, offers flexibility by specifying four criteria for when a waiver of consent can be approved or when any of the eight required elements of informed consent can be “altered” (the same standards apply to both situations). These criteria include: (1) subjects are exposed to no more than minimal risk; (2) the waiver or alteration does not adversely affect subject rights and welfare; (3) the research could not practicably be carried out without the waiver or alteration; and (4) subjects will be provided with additional pertinent information after participation, when appropriate (U.S. Department of Health and Human Services 1991a). However, institutional review boards (IRBs) may interpret the “impracticableness” requirement narrowly; use variable concepts of “minimal risks”; and link participants’ “rights” exclusively to autonomy interests, which may not be relevant in other cultural contexts. Neil Dickert and colleagues reframe the concept of a “valid” consent by detailing other ethical functions that consent promotes, beyond that of an autonomous authorization. Several focused at the participant level include (a) providing transparency, (b) allowing control and authorization, (c) promoting concordance with participants’ values, and (d) protecting and promoting welfare interests (Dickert et al. 2017). Their analysis helps them argue that it would still be ethically meaningful to partially engage potential participants in enrollment decisions with an “altered” consent process rather than a complete waiver in certain types of research. Our agenda is different, as we intend to show how consideration of their additional ethical functions can broaden the meaning of “impracticableness” and expand on the concept of “rights” to justify an “altered” consent process rather than requiring a traditional in-depth informed consent in international settings where different cultural norms exist. We anchor our discussion on a case involving a randomized crossover trial comparing adjuvant surgical oophorectomy and tamoxifen against placebo for breast cancer in Vietnam that took place in 1992–1993 and represented collaborative research between U.S. and local investigators (Love and Fost 1997). Due to lack of resources and systems of care in Vietnam, systemic adjuvant treatments were only occasionally used and when administered, followed regimens unlikely to achieve effectiveness. The investigators were made aware that it was not customary in Vietnam for patients to participate in their own medical decisions in the way that is normative in Western cultures. Patients expect and look to their physicians to tell them the appropriate treatment; Western notions of informed consent are inconsistent with a paternalistic style that is preferred by Vietnamese patients. While it was believed that it might be technically possible, though difficult, to discuss with Vietnamese women alternative options, an informed consent process that included alternative interventions would not be functionally relevant, as patients would defer to their doctors’ decisions regarding

Highly Efficient Perovskite Solar Cells with Substantial Reduction of Lead Content

Efficient Planar Perovskite Solar Cells Using Halide Sr-substituted Pb Perovskite

Lead-free solid-state organic–inorganic halide perovskite solar cells

Pseudohalide-Induced Recrystallization Engineering for CH3NH3PbI3 Film and Its Application in Highly Efficient Inverted Planar Heterojunction Perovskite Solar Cells

50% Sn-Based Planar Perovskite Solar Cell with Power Conversion Efficiency up to 13.6%

14.31 % Power Conversion Efficiency of Sn-Based Perovskite Solar Cells via Efficient Reduction of Sn4

(Invited) High Efficiency and Low Hysteresis Solar Cells Based on Perovskite with Triple Cation and Mixed Pb-Sn

Functional Polymer Passivating FA 0.85 PEA 0.15 SnI 3 for Efficient and Stable Lead-Free Perovskite Solar Cells

Sn‐Pb Binary Perovskite Films with High Crystalline Quality for High Performance Solar Cells

Low-bandgap Mixed Tin–lead Iodide Perovskite with Large Grains for High Performance Solar Cells

Suppressing Bulk and Interfacial Recombination Losses in Sn–Pb Perovskites for Efficient Printable Low‐Bandgap Photovoltaic Devices

Multifunctional anion-cation modulation engineering for Sn-Pb perovskite solar cells

Organic‐Free and Lead‐Free Perovskite Solar Cells with Efficiency over 11%

Realizing High Efficiency over 20% of Low‐Bandgap Pb–Sn‐Alloyed Perovskite Solar Cells by in Situ Reduction of Sn4+

Progress in Pb-free and less-Pb organic-inorganic hybrid perovskite solar cells

High‐Performance Inverted Planar Heterojunction Perovskite Solar Cells Based on Lead Acetate Precursor with Efficiency Exceeding 18%

Applicability of a Function-Based Approach to Informed Consent in International Settings

Over-18%-Efficiency Quasi-2D Ruddlesden–Popper Pb–Sn Mixed Perovskite Solar Cells by Compositional Engineering

Efficient and Reproducible Ch3nh3pbi3-X(Scn)(X) Perovskite Based Planar Solar Cells

Mixed-Organic-Cation Tin Iodide for Lead-Free Perovskite Solar Cells with an Efficiency of 8.12.

Numerical simulation and optimization of lead free CH3NH3SnI3 perovskite solar cell with CuSbS2 as HTL using SCAPS 1D